Pulmonary delivery of favipiravir inhalation solution for COVID-19 treatment: in vitro characterization, stability, in vitro cytotoxicity, and antiviral activity using real time cell analysis için istatistikler
Toplam ziyaret
| views | |
|---|---|
| Pulmonary delivery of favipiravir inhalation solution for COVID-19 treatment: in vitro characterization, stability, in vitro cytotoxicity, and antiviral activity using real time cell analysis | 0 |
Aylık toplam ziyaret
| views | |
|---|---|
| Ağustos 2024 | 0 |
| Eylül 2024 | 0 |
| Ekim 2024 | 0 |
| Kasım 2024 | 0 |
| Aralık 2024 | 0 |
| Ocak 2025 | 0 |
| Şubat 2025 | 0 |
Dosya Ziyaretleri
| views | |
|---|---|
| Yildiz-pekoz-2022-Pulmonary-delivery-of-favipiravir-i.pdf | 2 |
